Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy

Overview of attention for article published in Drug Design, Development and Therapy, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies

Article in Journal of the Canadian Association of Gastroenterology (May 2024)

The role of filgotinib in ulcerative colitis and Crohn’s disease

Article in Immunotherapy (November 2023)

Network Meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis

Preprint in Research Square (November 2023)